Ki-Si: A New Marker for Breast Cancer Cell Proliferation
Author Information
Author(s): R.S. Camplejohn, A. Brock, D.M. Barnes, C. Gillett, B. Raikundalia, H. Kreipe, M.R. Parwaresch
Primary Institution: Richard Dimbleby Department of Cancer Research, UMDS, St Thomas' Hospital, London
Hypothesis
The novel proliferation-associated antibody Ki-Si can serve as a reliable marker for assessing cell proliferation in breast cancer.
Conclusion
Ki-Si staining intensity correlates with the S-phase fraction in breast cancer cells, indicating its potential as a robust proliferation marker.
Supporting Evidence
- Ki-Si staining intensity increased linearly through the S-phase and peaked in mitosis.
- Ki-Si staining correlated with S-phase fraction derived from DNA profiles in breast carcinoma samples.
- Staining with Ki-Si was found to be robust, resisting degradation by fixation.
Takeaway
Researchers found a new marker called Ki-Si that helps doctors see how fast breast cancer cells are growing, which can help in treating the disease.
Methodology
The study involved flow cytometric analysis of Ki-Si staining in a human breast cell line and clinical breast carcinoma samples, assessing the correlation with S-phase fraction.
Limitations
The study is preliminary and involves a small sample size, which may limit the generalizability of the findings.
Participant Demographics
The study included 15 cases of breast carcinoma with varying S-phase fractions.
Statistical Information
P-Value
0.03
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website